This award is designed to support creative individuals who wish to pursue innovative research approaches that support NIH HIV/AIDS Research Priorities and have the potential to benefit substance using populations with or at risk for HIV.
Donor Name: National Institutes of Health (NIH)
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 08/15/2025
Size of the Grant: $1,500,000
Grant Duration: 4 years
Details:
Avenir means future in French. Accordingly, this Avenir program looks towards the future by supporting early stage investigators (ESI) proposing highly innovative studies at the nexus of substance use disorders (SUD) and HIV. Applications responding to this FOA should clearly describe the nexus with substance use and/or SUD. The Avenir Award Program for research on the intersection of SUD and HIV will support research approaches, both basic and clinical, focused on improving therapies for HIV, preventing HIV transmission, reducing the impact of comorbid conditions, and ultimately, eradicating HIV. Examples of studies of relevance to substance use and SUD include: studies in people with SUD or samples from substance using populations; studies using in vitro systems and/or animal models that test the effects of addictive substances on HIV pathogenesis, disease progression, or treatment; and studies to develop interventions or treatments that are tailored to people with SUD. The award will support investigators in early stages of their careers who may lack the preliminary data required for an R01 grant, nonetheless, propose high priority, high impact research, and demonstrate promise of being tomorrow’s leaders in the field.
The National Institute on Drug Abuse (NIDA) has supported highly innovative investigators, often in advanced career stages, proposing potentially transformative research through a companion award, the ‘Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1).’ The HIV Avenir program is designed to complement the NIDA HIV Avant-Garde program by focusing on ESI. Avenir applicants may propose research in any area of high priority HIV/AIDS research that has the potential to open new areas of HIV/AIDS research and/or lead to new avenues for treatment and prevention of HIV/AIDS among substance users.
Funding Information
- Application budgets are limited to $375,000 in Direct Costs each year for up to four years, plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.
- Awards are multi-year funded, with all funds being disbursed in the first year of the award. Awards will be up to $1,500,000 in direct costs (the equivalent of $375,000 in Direct Costs each year for four years) plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period allowed is 4 years.
Eligible Applicants
- Public housing authorities/Indian housing authorities
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Special district governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- County governments
- Private institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- City or township governments
- Small businesses
- Public and State controlled institutions of higher education
- State governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For more information, visit Grants.gov.
